Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoline Lerang

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Lupus Science & Medicine|October 16, 2023
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosusAnna Hedenstedt, Sarah Reid, Ahmed Sayadi, et al.
Journal of Internal Medicine|November 7, 2025
Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large-scale analysis of genetic predisposition and disease subtypesSarah Reid, Johanna K Sandling, Pascal Pucholt, et al.
Annals of the Rheumatic Diseases|March 26, 2021
Interaction between the <i>STAT4</i> rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosusSarah Reid, Niklas Hagberg, Johanna K Sandling, et al.
JCI Insight|December 8, 2022
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndromeXavier Mariette, Francesca Barone, Chiara Baldini, et al.
Rheumatology (Oxford, England)|October 4, 2018
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitidesTorhild Garen, Karoline Lerang, Anna-Maria Hoffmann-Vold, et al.
The Lancet. Rheumatology|November 22, 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countriesEleana Bolla, Anne Grete Semb, Michelle Petri, et al.
Genes and Immunity|June 15, 2021
Variants in BANK1 are associated with lupus nephritis of European ancestryKarin Bolin, Juliana Imgenberg-Kreuz, Dag Leonard, et al.
Annals of the Rheumatic Diseases|October 10, 2020
Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencingJohanna K Sandling, Pascal Pucholt, Lina Hultin Rosenberg, et al.
Rheumatology (Oxford, England)|December 12, 2025
International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by systemic lupus erythematosus patients: the SLE Knowledge Assessment score (SLAKE)Antonin Satrin, Matteo Piga, Mariele Gatto, et al.
The Lancet. Rheumatology|June 15, 2024
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countriesEleana Bolla, Anne Grete Semb, Anne M Kerola, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Lupus Science & Medicine|October 16, 2023
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosusAnna Hedenstedt, Sarah Reid, Ahmed Sayadi, et al.
Journal of Internal Medicine|November 7, 2025
Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large-scale analysis of genetic predisposition and disease subtypesSarah Reid, Johanna K Sandling, Pascal Pucholt, et al.
Annals of the Rheumatic Diseases|March 26, 2021
Interaction between the <i>STAT4</i> rs11889341(T) risk allele and smoking confers increased risk of myocardial infarction and nephritis in patients with systemic lupus erythematosusSarah Reid, Niklas Hagberg, Johanna K Sandling, et al.
JCI Insight|December 8, 2022
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndromeXavier Mariette, Francesca Barone, Chiara Baldini, et al.
Rheumatology (Oxford, England)|October 4, 2018
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitidesTorhild Garen, Karoline Lerang, Anna-Maria Hoffmann-Vold, et al.
The Lancet. Rheumatology|November 22, 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countriesEleana Bolla, Anne Grete Semb, Michelle Petri, et al.
Genes and Immunity|June 15, 2021
Variants in BANK1 are associated with lupus nephritis of European ancestryKarin Bolin, Juliana Imgenberg-Kreuz, Dag Leonard, et al.
Annals of the Rheumatic Diseases|October 10, 2020
Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencingJohanna K Sandling, Pascal Pucholt, Lina Hultin Rosenberg, et al.
Rheumatology (Oxford, England)|December 12, 2025
International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by systemic lupus erythematosus patients: the SLE Knowledge Assessment score (SLAKE)Antonin Satrin, Matteo Piga, Mariele Gatto, et al.
The Lancet. Rheumatology|June 15, 2024
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countriesEleana Bolla, Anne Grete Semb, Anne M Kerola, et al.
Pageof 2